What is the difference between protecting patient privacy and blocking access to electronic health information?

Protecting privacy means limiting disclosure to authorized purposes, using safeguards, and applying exceptions where the rule allows them. Information blocking occurs when access, exchange, or use is interfered with, prevented, or materially discouraged without a valid basis. A compliant programme preserves patient access while controlling who else can see the data and under what conditions.

Why this is a governance and access-control distinction, not a privacy synonym

Protecting patient privacy and blocking access to electronic health information solve different problems. Privacy controls limit disclosure to authorized purposes and users, while information blocking is about whether access, exchange, or use is being interfered with or discouraged without a valid basis. The practical distinction is that a compliant programme must both protect sensitive data and preserve legitimate patient access.

That means a privacy rule can justify narrowing who sees data, but it should not be used as a blanket reason to prevent timely exchange, patient portal access, or necessary disclosures. In other words, privacy is about controlled sharing; blocking is about unnecessarily stopping the flow of information.

Where the two duties overlap in real healthcare workflows

They often meet at the same control points: portal permissions, release-of-information workflows, care-team access, API-based exchange, and third-party requests. The same dataset may need different treatment depending on whether the requester is the patient, a treating clinician, a business associate, or another covered workflow. The decision hinges on authorization, purpose, and the legal basis for disclosure, not on a one-size-fits-all denial rule.

A useful way to test the difference is to ask whether the control is preventing unauthorized disclosure or preventing a legitimate user from getting data they are entitled to receive. A privacy safeguard should reduce unnecessary exposure, but it should still allow lawful access paths to function.

For healthcare environments, that balance is especially important where account and access design already affects patient care delivery. NHIMG’s Healthcare Identity Security Guide is useful here because the same access models that protect clinician and third-party access also shape whether patient data exchange stays usable.

What usually makes privacy protection turn into information blocking

The failure mode is usually not a malicious intent to obstruct care. It is a control that becomes overbroad, poorly documented, or operationally rigid. Common examples include blanket denials, slow manual approvals with no clear exception handling, over-filtering of records, or policies that confuse “minimum necessary” with “no access at all.”

The boundary is crossed when access, exchange, or use is materially discouraged without a valid basis. That can happen even if the organisation believes it is being cautious. The issue is whether the restriction is proportionate and justified for the specific request.

For privacy, the better question is whether the disclosure is limited to what is authorized and whether safeguards are in place to reduce unnecessary exposure. For blocking, the better question is whether the workflow is creating an avoidable barrier to lawful exchange or patient access.

Risk and Threat Considerations

Overcorrecting toward denial creates two risks at once: patients can be delayed in obtaining their own records, and legitimate clinical exchange can be slowed or frustrated. In healthcare, that can affect continuity of care, operational trust, and regulatory exposure if the restriction is not supported by a valid basis.

Failure mechanism: Organisations often apply privacy controls as a blanket refusal pattern, then fail to distinguish between disclosure limits and access rights. The result is a workflow that blocks exchange or materially discourages use even when the request should be permitted.

Impact: Patients may lose timely access, clinicians may lack needed context, and the organisation may create avoidable compliance risk because the control is acting as a barrier instead of a safeguard.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

NIST SP 800-53 Rev 5 and NIST CSF 2.0 set the technical controls, while ISO/IEC 27001:2022, GDPR and SOC 2 (AICPA) define the regulatory obligations.

Framework	Control / Reference	Relevance
NIST SP 800-53 Rev 5	AC-3 — Access Enforcement	Access decisions determine who may see or exchange health information.
	AC-6 — Least Privilege	Limits exposure while still supporting valid clinical and patient access.
	AR-8 — Accounting of Disclosures	Tracks disclosures so privacy protections remain auditable and justified.
Recommendation — Enforce approved access decisions so privacy controls do not become blanket denials. Restrict access to the minimum needed without impeding lawful exchange. Maintain disclosure accountability to distinguish authorized sharing from blocking.
ISO/IEC 27001:2022	A.5.15 — Access control	Controls who can access information, which is central to privacy and blocking decisions.
	A.5.34 — Privacy and protection of PII	Directly addresses privacy safeguards for personal health information.
Recommendation — Apply access control rules that preserve legitimate health-data exchange. Implement privacy safeguards that limit disclosure without suppressing lawful access.
GDPR	Art.5 — Principles relating to processing of personal data	Supports lawful, purpose-limited processing and data minimisation.
	Art.25 — Data protection by design and by default	Requires privacy controls built into systems without over-restricting lawful use.
Recommendation — Align processing with purpose limitation and data minimisation. Design systems to protect privacy by default while keeping valid access paths open.
NIST CSF 2.0	PR.AA-05 — Identity Management, Authentication, and Access Control	Access control is the mechanism that must separate privacy from blocking.
Recommendation — Implement access controls that protect data without preventing authorized exchange.
SOC 2 (AICPA)	CC6.1 — Logical Access Security Software, Infrastructure, and Architectures	Covers logical access controls over sensitive information and workflows.
Recommendation — Use logical access controls that preserve authorized patient information flow.

Practitioner Guidance

What to verify: Check whether each restriction is tied to a defined disclosure purpose, a documented exception, or a real security need. If the answer is only “we do not want data to leave,” the control is probably too broad for a patient-information context.

Decision rule: If a control limits who can see data, test it as a privacy safeguard; if it prevents the patient or another entitled party from getting data, test it as a potential blocking issue. Treat those as different review paths even when they use the same workflow.

What good looks like: The organisation can show that patient privacy is preserved without breaking lawful exchange, and it can explain why any denial was necessary, proportionate, and traceable to a valid basis rather than to convenience or excessive caution.

Practitioner takeaway: The best design protects sensitive health information by narrowing unnecessary disclosure, but it never uses privacy as the reason to obstruct lawful access or exchange.